Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2012 09:32 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration

DUBLIN, Calif., and CAMBRIDGE, UK, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small...
September 04, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference

DUBLIN, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
August 30, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at September Investor Conferences

DUBLIN, Calif., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
August 20, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery

DUBLIN, Calif., Aug. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
July 30, 2012 16:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Reports 2012 Second Quarter Financial Results

Dacogen Royalty Revenue Increased 25% From Prior Year $5.4 Million Earned on Phase I Trial Initiation of FGFR Kinase Inhibitor Dacogen Receives Positive Regulatory Recommendation in the EU for...
July 24, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Announce 2012 Second Quarter Financial Results on July 30, 2012

DUBLIN, Calif., July 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
July 20, 2012 10:34 ET | Source: Astex Pharmaceuticals, Inc.

DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia

DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
July 10, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Board Member Wins 2012 European Mediscience Award

DUBLIN, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
June 22, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients

DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
June 13, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor

DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right